BIFFI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 10.633
EU - Europa 8.861
AS - Asia 8.350
AF - Africa 557
SA - Sud America 523
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 6
Totale 28.947
Nazione #
US - Stati Uniti d'America 10.556
SG - Singapore 2.530
GB - Regno Unito 2.425
VN - Vietnam 2.362
CN - Cina 2.007
IT - Italia 1.800
DE - Germania 1.219
UA - Ucraina 815
SE - Svezia 605
HK - Hong Kong 590
RU - Federazione Russa 532
IN - India 484
FR - Francia 435
BR - Brasile 376
IE - Irlanda 291
EE - Estonia 215
CI - Costa d'Avorio 179
NL - Olanda 166
ZA - Sudafrica 163
JP - Giappone 142
FI - Finlandia 115
TG - Togo 83
SC - Seychelles 76
AR - Argentina 71
KR - Corea 66
BG - Bulgaria 46
CA - Canada 43
JO - Giordania 39
CH - Svizzera 38
IR - Iran 31
AT - Austria 28
NG - Nigeria 27
BE - Belgio 26
MX - Messico 26
BD - Bangladesh 19
CL - Cile 19
ID - Indonesia 19
EC - Ecuador 18
PL - Polonia 17
CO - Colombia 16
ES - Italia 15
GR - Grecia 14
AU - Australia 13
RO - Romania 13
EG - Egitto 12
PY - Paraguay 12
IQ - Iraq 9
CZ - Repubblica Ceca 8
LB - Libano 8
LT - Lituania 8
TR - Turchia 8
UZ - Uzbekistan 8
MY - Malesia 7
UY - Uruguay 7
MA - Marocco 5
EU - Europa 4
HR - Croazia 4
KZ - Kazakistan 4
LU - Lussemburgo 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
DK - Danimarca 3
NZ - Nuova Zelanda 3
PE - Perù 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
NO - Norvegia 2
PK - Pakistan 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TN - Tunisia 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BZ - Belize 1
DZ - Algeria 1
ET - Etiopia 1
GI - Gibilterra 1
GP - Guadalupe 1
HU - Ungheria 1
KE - Kenya 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
PF - Polinesia Francese 1
SI - Slovenia 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 28.946
Città #
Southend 2.147
Singapore 1.672
Fairfield 1.166
Ashburn 1.150
Chandler 661
Hong Kong 587
Jacksonville 585
Wilmington 581
Woodbridge 530
Seattle 513
Princeton 512
Houston 508
Santa Clara 492
Dong Ket 457
Cambridge 419
Ho Chi Minh City 390
Ann Arbor 318
Hanoi 294
Dublin 290
Boardman 284
Beijing 265
Padova 233
Westminster 232
Nanjing 213
Abidjan 179
Hefei 156
Los Angeles 148
Milan 147
Berlin 144
Tokyo 141
Saint Petersburg 122
Shenyang 122
Medford 115
Jinan 107
Buffalo 104
Helsinki 103
Rome 98
Bologna 88
Changsha 88
Mülheim 88
San Diego 87
Lomé 83
New York 78
Bremen 73
Mahé 72
Hebei 69
Turin 69
Nanchang 63
Dallas 58
Redondo Beach 57
Seoul 55
Jiaxing 53
Des Moines 51
Guangzhou 46
Zhengzhou 46
Munich 45
Tianjin 45
Olalla 44
Sofia 44
Frankfurt am Main 41
São Paulo 41
Amman 39
Yubileyny 38
Ningbo 36
Shanghai 35
Hangzhou 34
Chicago 33
Haiphong 32
Bari 30
Naples 29
Verona 29
Da Nang 28
Dearborn 27
Abeokuta 26
Brussels 26
Taizhou 26
Falkenstein 25
Falls Church 25
Norwalk 25
Haikou 24
Mountain View 24
Biên Hòa 23
Lanzhou 23
Toronto 21
London 20
Phoenix 20
Bengaluru 19
Brooklyn 19
Florence 19
Ninh Bình 19
Bern 18
Chengdu 18
Hải Dương 18
Quận Bình Thạnh 18
Düsseldorf 17
Ha Long 17
Quận Một 17
San Venanzo 17
Bühl 16
Vũng Tàu 16
Totale 18.615
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.033
Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD) 312
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 267
Resynchronization for HemodYnamic Treatment for Heart Failure Management II (RHYTHM II) Investigators. A prospective randomized evaluation of VV delay optimization in CRT-D recipients:echocardiographic observations from the RHYTHM II ICD study. 251
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 222
Atrial fibrillation: it is better to be alone than in bad company! 218
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 209
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 198
AF burden is important - Fact or fiction? 196
Bridging the future of cardiac stimulation: physiologic or leadless pacing? 193
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 190
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 187
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 186
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 185
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 185
Automatic verification of ventricular stimulation: fusion management algorithm 177
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 176
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 174
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 174
Atrial fibrillation ablation: beyond electro-mechanical matters 172
Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead 170
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 166
Automatic management of left ventricular stimulation: hints for technologic improvement. 163
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 163
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 162
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 161
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 159
Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death. 158
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. 158
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 158
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 156
Evaluation of fusion beat detection with a new ventricular automatic capture algorithm in ICDs. 155
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 155
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 155
Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study 154
Implantation of cardioverter-defibrillator: Effects on shoulder function. 152
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 152
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 151
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 151
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 150
A prospective randomized evaluation of VV delay optimization in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 149
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 149
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 149
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 149
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 148
The "Subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: An observational prospective multicenter study 148
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 147
Automatic management of left ventricular pacing output: effectiveness of stimulation and device longevity. Proceedings XIII International symposium on Progress in Clinical Pacing 145
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 145
Atrial fibrillation and heart failure: does one epidemic feed he other? 145
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 144
Cardiac resynchronization therapy : effects on left and right ventricular ejection fraction during exercise 144
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 143
Outcomes with dronedarone in atrial fibrillation: What differences between real-world practice and trials? A meta-analysis and meta-regression analysis 142
Evaluation of the atrial evoked response for capture detection with high-polarization leads. 141
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 141
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 140
Decrease in patient radiation exposure by a tantalum filter during electrophysiological procedures. 140
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices 138
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 138
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients 138
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 137
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 137
Predictors of long-term survival free from relapses after extraction of infected CIED. 137
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 137
Implantable electrical devices for prevention of sudden cardiac death: data on implant rates from a 'real world' regional registry. 136
Phrenic stimulation: a challenge for cardiac resynchronization therapy 136
Cardiac resynchronisation therapy: effect on diastolic function –Evaluation by radionuclide angiography 135
Cardiac resynchronization therapy: is systole all that matters? 135
Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry. 134
Less is more: Can we achieve cardiac resynchronization with 2 leads only? 133
Role of drugs and devices in patients at risk of sudden cardiac death. 133
Expenditure and value for money: the challenge of implantable cardioverter defibrillators 132
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 132
Atrial fibrillation: Adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction. 131
The QRS interval in patients treated with resynchronization therapy: which value 130
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. 129
Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death 128
A plateau waveform shape allows a much higher patient shock energy tolerance 128
Cardiac resynchronization therapy and VV interval optimization: which relationship between QRS width and the results of echo-guided VV interval optimization? 128
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 128
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy. 128
Automatic verification of ventricular stimulation: fusion management algorithm 128
Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. 127
Prediction of atrial fibrillation in patients with an implantable cardioverter-defibrillator and heart failure. 127
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 127
La fibrillazione atriale e il controllo della frequenza ventricolare: approccio terapeutico e valutazione dell’efficacia del trattamento 127
Peri-operative management of patients taking antithrombotic therapy: need for an integrated proactive approach. 127
Left ventricular rotational mechanics in acute myocardial infarction and in chronic (ischemic and nonischemic) heart failure patients. 127
Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial. 126
Atrial evoked response signal quality in heart failure patients 125
Is cardiac resynchronization therapy cost-effective? 125
Cardiac resynchronization therapy: a cost or an investment? 125
Effects of cardiac resynchronization therapy on left ventricular twist. 124
Atrial fibrillation in patients with cardiac resynchronization therapy: Clinical management and outcome 124
Cardiac resynchronisation therapy: effect on intra-ventricular and inter-ventricular dyssynchrony at radionuclide angiography by Fourier phase analysis 123
Cardioversione elettrica di fibrillazione atriale associata ad impianto di dispositivo per la resincronizzazione cardiaca: quali i risulatati a lungo termine? 122
Il follow up di pace maker e defibrillatori: Valutazione degli attuali disagi per i pazienti e del potenziale impatto di sistemi di controllo remoto mediante telemedicina. Abstract 69° Congresso Nazionale Società Italiana di Cardiologia 122
Cardiac resynchronization therapy: Implant rates, temporal trends and relationships with heart failure epidemiology 121
Cardioversione elettrica associata ad impianto di dispositivo per resincronizzazione cardiaca: quali risultati a distanza? 121
Totale 16.109
Categoria #
all - tutte 75.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.252 0 0 0 0 0 141 43 174 206 180 144 1.364
2021/20223.655 340 192 257 282 352 256 67 285 109 139 613 763
2022/20233.778 405 475 208 492 196 241 108 209 666 194 332 252
2023/20241.084 88 176 75 75 118 189 78 60 64 61 41 59
2024/20254.289 177 923 320 335 812 206 192 105 55 232 120 812
2025/20264.969 1.105 749 935 593 1.004 583 0 0 0 0 0 0
Totale 29.334